Access our full collection of sustainable healthcare resources, such as toolkits, case studies, publications and more. You can also add new resources to the library.
Sharing our newest publication in Society Of Critical Care Medicine JournalCritical Care Explorations: “Implementing a Green ICU Pathway Across a Large U.S. Health System.” Across 8 hospitals and 400+…
Published date
August 2026
•
by
Masud, F. N., Khan, A. H., Fischer, J. F., Estay, A. F., Gooch, M. E., Blackburn, L. M., Lozada, C., & Sasangohar, F
This editorial argues that regional citrate anticoagulation is a greener and clinically preferable alternative to heparin in haemodialysis. Heparin is extracted from pig intestinal mucosa, with one…
Worldwide, the number of people who need lifesaving kidney replacement therapy (KRT) steadily increases, but approximately two thirds of them lack access to KRT and therefore die. Access to KRT…
Published date
February 2025
•
by
Wieringa, FP., Suran, s., Søndergaard, H., Ash, S., Cummins, C., Chaudhuri, AR., Irmak, T., Gerritsen, K., Vollenbroek, J.
Green nephrology has often focussed on dialysis, with its intensive use of water and energy. In comparison, non-dialysis outpatient care of chronic kidney disease (CKD) has received less attention.…
Published date
March 2026
•
by
Berman-Parks, N., Rho, E., Stoneman, S., Woywodt, A., Torreggiani, M.
AbstractThe European Kidney Health Alliance’s 2023 annual Policy Forum brought together relevant stakeholder groups and examined the impact of the environment on kidney health and of kidney…
Published date
June 2025
•
by
van Vredendaal, OP., Bé, A., de Barbieri, I., Gallego, D., Loud, F., Piccoli, GB., Wieringa, F., Vanholder, R.
AbstractBackgroundHealthcare contributes significantly to global carbon dioxide equivalent emissions, with kidney care contributing disproportionately to this. Renal medicine was one of the first…
Background: Incremental hemodialysis (HD) is the process whereby the frequency of HD is adapted to the patient’s residual kidney function, initially starting at twice a week with an increase based on…
Published date
•
by
Taha, A., Messina, A., Tom, A., Altar, RI., Filteau, N., Blum, D., Trinh, E., Weber, CL.
ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascular–kidney–metabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus…
AbstractThe burden of chronic kidney disease (CKD) and its risk factors are projected to rise in parallel with the rapidly ageing global population. By 2050, the prevalence of CKD category G3–G5 may…
Published date
July 2024
•
by
Chesnaye, NC., Ortiz, A., Zoccali, C., Stel, VS., Jager, KJ.
Diabetes is the most common cause of chronic kidney disease (CKD), a condition found in 850 million persons and projected to become the fifth global cause of death by 2040. Research is needed that…
